Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Vasikaran

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Clinical Chemistry and Laboratory Medicine|January 31, 2018
Assessment of bone turnover in osteoporosis: harmonization of the total testing processSamuel Vasikaran
The Clinical Biochemist. Reviews|October 15, 2008
Interpretative commentingSamuel Vasikaran
EJIFCC|October 16, 2020
Trends in Laboratory Testing Practice for Diabetes MellitusMithu Banerjee, Samuel Vasikaran
Annals of Laboratory Medicine|March 6, 2012
Current recommendations for laboratory testing and use of bone turnover markers in management of osteoporosisJehoon Lee, Samuel Vasikaran
Practical Laboratory Medicine|July 21, 2021
Interpretative commenting in clinical chemistry with worked examples for thyroid function test reportsSamuel Vasikaran, Tze Ping Loh
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|August 4, 2011
Official Positions for FRAX® clinical regarding biochemical markers from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®Eugene V McCloskey, Samuel Vasikaran, Cyrus Cooper, et al.
Clinical Biochemistry|December 19, 2015
Comparison of clinical cut-points and treatment targets for urine NTX and plasma βCTX-I in osteoporosisS A Paul Chubb, Christine Mandelt, Samuel Vasikaran
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 17, 2018
Clinical utility of bone turnover markers in the management of common metabolic bone diseases in adultsPaul Glendenning, S A Paul Chubb, Samuel Vasikaran
European Journal of Endocrinology|June 7, 2020
Bone turnover marker monitoring in osteoporosis treatment responseRui Zhen Tan, Tze Ping Loh, Samuel Vasikaran
Pathology|February 15, 2025
Influence of analytical bias and imprecision on the clinical performance of reference intervalsRui Zhen Tan, Corey Markus, Samuel Vasikaran, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Clinical Chemistry and Laboratory Medicine|January 31, 2018
Assessment of bone turnover in osteoporosis: harmonization of the total testing processSamuel Vasikaran
The Clinical Biochemist. Reviews|October 15, 2008
Interpretative commentingSamuel Vasikaran
EJIFCC|October 16, 2020
Trends in Laboratory Testing Practice for Diabetes MellitusMithu Banerjee, Samuel Vasikaran
Annals of Laboratory Medicine|March 6, 2012
Current recommendations for laboratory testing and use of bone turnover markers in management of osteoporosisJehoon Lee, Samuel Vasikaran
Practical Laboratory Medicine|July 21, 2021
Interpretative commenting in clinical chemistry with worked examples for thyroid function test reportsSamuel Vasikaran, Tze Ping Loh
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|August 4, 2011
Official Positions for FRAX® clinical regarding biochemical markers from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®Eugene V McCloskey, Samuel Vasikaran, Cyrus Cooper, et al.
Clinical Biochemistry|December 19, 2015
Comparison of clinical cut-points and treatment targets for urine NTX and plasma βCTX-I in osteoporosisS A Paul Chubb, Christine Mandelt, Samuel Vasikaran
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 17, 2018
Clinical utility of bone turnover markers in the management of common metabolic bone diseases in adultsPaul Glendenning, S A Paul Chubb, Samuel Vasikaran
European Journal of Endocrinology|June 7, 2020
Bone turnover marker monitoring in osteoporosis treatment responseRui Zhen Tan, Tze Ping Loh, Samuel Vasikaran
Pathology|February 15, 2025
Influence of analytical bias and imprecision on the clinical performance of reference intervalsRui Zhen Tan, Corey Markus, Samuel Vasikaran, et al.
Pageof 4